Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
01/02/2002 | EP1165472A1 Methods for the preparation of biphenyl isoxazole sulfonamides |
01/02/2002 | EP1165084A1 Inhibitors of prenyl-protein transferases |
01/02/2002 | EP1165082A1 Inhibitors of prenyl-protein transferase |
01/02/2002 | EP1165013A2 Inhibitors of prenyl-protein transferase |
01/02/2002 | EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions |
01/02/2002 | CN1329610A Chromenone and chromanone derivatives as integrin inhibitors |
01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
01/02/2002 | CN1328824A Compound for curing female sexual disorder |
01/01/2002 | US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment |
01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
01/01/2002 | US6335451 Five-membered heterocycles having biphenylsulfonyl substitution, with sulfonylcyanamide side chain, compositions containing them, and methods of using them |
01/01/2002 | US6335445 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
01/01/2002 | US6335440 Method for detecting oligonucleotides using energy transfer dyes with long stoke shift |
01/01/2002 | US6335343 Inhibitors of prenyl-protein transferase |
01/01/2002 | US6335334 Hypertensive agents, anticoagulants; cardiovascular and sexual disorders, angina pectoris, and atherosclerosis |
12/27/2001 | WO2001098276A1 Para-aminophenol derivatives and their use as developers for producing oxidation colorations |
12/27/2001 | WO2001098263A1 Method for producing aliphatic sulphonic acid chlorides from sulphonic acids |
12/27/2001 | WO2001097860A2 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
12/27/2001 | WO2001097810A2 Use of therapeutic benzamide derivatives |
12/27/2001 | WO2001028979A3 Inhibitors of neuraminidases |
12/27/2001 | WO2000064864A9 N-protected amines and their use as prodrugs |
12/27/2001 | US20010056123 Benzamidine derivatives |
12/27/2001 | US20010056110 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
12/27/2001 | US20010056109 Imidazole derivatives |
12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
12/26/2001 | CN1328466A Use of antifungal agents for treating scleroses |
12/26/2001 | CN1327986A Ion type liquid |
12/26/2001 | CA2351215A1 Use of ergothioneine and/or its derivatives as an antiglycation agent |
12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
12/25/2001 | US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents |
12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
12/20/2001 | WO2001096313A1 Distamycin a analogs |
12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
12/20/2001 | WO2001096305A1 Serine protease inhibitors |
12/20/2001 | WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
12/20/2001 | WO2001051456A3 Antibacterial agents |
12/20/2001 | US20010053851 Antidiabetic agents |
12/20/2001 | US20010053823 Polyimidazoles |
12/20/2001 | DE10028950A1 High yield caprolactam production by catalytic hydrogenation of a cyanovaleric acid derivative, followed by catalytic cyclization of the aminocaproic acid derivative-containing mixture obtained |
12/19/2001 | EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
12/19/2001 | EP0813564B1 Mannich base polymers |
12/19/2001 | CN1327443A Substituted anilides |
12/19/2001 | CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
12/19/2001 | CN1326936A Ion liquid |
12/18/2001 | US6331633 Antidiabetic agents with no liver toxicity |
12/18/2001 | US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors |
12/18/2001 | US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders |
12/18/2001 | US6331542 Protease inhibitors |
12/18/2001 | US6331507 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
12/18/2001 | CA2006309C Azolylmethylcyclopentane benzylidene fungicide |
12/13/2001 | WO2001094318A2 Method for synthesis of substituted azole libraries |
12/13/2001 | WO2001094317A2 Method for synthesis of substituted azole libraries |
12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
12/13/2001 | WO2001036660A3 Transition metal complexes attached to a polymer via a flexible chain |
12/13/2001 | US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis |
12/13/2001 | US20010051614 Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
12/13/2001 | US20010049848 Direct dyes; hair dyes |
12/13/2001 | DE10027995A1 Ionische Flüssigkeiten II Ionic Liquids II |
12/13/2001 | DE10001037C1 Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen Processes and intermediates for the preparation of imidazopyridines |
12/12/2001 | EP1162204A1 Ionic liquids |
12/12/2001 | EP1161429A2 Heterocyclic compounds as adenosine deaminase inhibitors |
12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
12/12/2001 | EP0912499B1 Pesticides |
12/12/2001 | CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts |
12/11/2001 | US6329529 Nitrogen-based halogenating agents and process for preparing halogen-containing compounds |
12/11/2001 | US6329404 Pharmaceutical composition |
12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
12/11/2001 | US6329374 Non-systemic control of parasites |
12/11/2001 | US6329371 α-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient |
12/11/2001 | US6329369 Methods of treating pain and other conditions |
12/11/2001 | US6329360 Hetero-linked phenylglycinolamides |
12/11/2001 | US6329194 Quantitative analysis |
12/11/2001 | US6329154 Histamine measuring apparatus and a histamine measuring method |
12/06/2001 | WO2001092229A1 TNF-α PRODUCTION INHIBITORS |
12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
12/06/2001 | WO2001092215A2 Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same |
12/06/2001 | WO2001091807A2 Ethylenedicysteine (ec)-drug conjugates |
12/06/2001 | WO2001091752A1 Melanocortin receptor agonists |
12/06/2001 | US20010049446 C-C9-Heteroaryl, linked via C or N, substituted or unsubstitued by 1,3-substituents, substituted benzoylguanidine derivatives useful for treating ischemia, cardiac infarct, angina pectoris, and storke etc. |
12/06/2001 | US20010049367 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
12/06/2001 | DE10026565A1 Ionische Flüssigkeiten Ionic Liquids |
12/06/2001 | CA2736344A1 Tnf-.alpha. production inhibitors |
12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
12/06/2001 | CA2410597A1 Melanocortin receptor agonists |
12/05/2001 | EP1160249A2 Ionic liquids |
12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
12/05/2001 | EP1159275A2 Imidazole compounds as histamine h3 ligands |
12/05/2001 | EP1159264A2 INHIBITORS OF FACTOR Xa |
12/05/2001 | EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors |
12/05/2001 | EP1159261A2 Antizyme modulators and their use |
12/05/2001 | EP1158983A1 Inhibitors of prenyl-protein transferase |
12/05/2001 | EP1158982A2 Inhibitors of prenyl-protein transferase |
12/05/2001 | EP0991793B1 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters |
12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
12/05/2001 | CN1325385A Gastrin and cholecystokinin receptor ligands |